291 related articles for article (PubMed ID: 9164976)
1. Enhancement of gp130-mediated tyrosine phosphorylation of STAT3 and its DNA-binding activity in dexamethasone-treated AIDS-associated Kaposi's sarcoma cells: selective synergy between dexamethasone and gp130-related growth factors in Kaposi's sarcoma cell proliferation.
Murakami-Mori K; Mori S; Taga T; Kishimoto T; Nakamura S
J Immunol; 1997 Jun; 158(11):5518-26. PubMed ID: 9164976
[TBL] [Abstract][Full Text] [Related]
2. AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies.
Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
J Clin Invest; 1995 Sep; 96(3):1319-27. PubMed ID: 7657807
[TBL] [Abstract][Full Text] [Related]
3. AIDS-related Kaposi's sarcoma: evidence for direct stimulatory effect of glucocorticoid on cell proliferation.
Guo WX; Antakly T
Am J Pathol; 1995 Mar; 146(3):727-34. PubMed ID: 7887453
[TBL] [Abstract][Full Text] [Related]
4. The soluble form of the IL-6 receptor (sIL-6R alpha) is a potent growth factor for AIDS-associated Kaposi's sarcoma (KS) cells; the soluble form of gp130 is antagonistic for sIL-6R alpha-induced AIDS-KS cell growth.
Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
Int Immunol; 1996 Apr; 8(4):595-602. PubMed ID: 8722639
[TBL] [Abstract][Full Text] [Related]
5. Endogenous basic fibroblast growth factor is essential for cyclin E-CDK2 activity in multiple external cytokine-induced proliferation of AIDS-associated Kaposi's sarcoma cells: dual control of AIDS-associated Kaposi's sarcoma cell growth and cyclin E-CDK2 activity by endogenous and external signals.
Murakami-Mori K; Mori S; Nakamura S
J Immunol; 1998 Aug; 161(4):1694-704. PubMed ID: 9712033
[TBL] [Abstract][Full Text] [Related]
6. p38MAP kinase is a negative regulator for ERK1/2-mediated growth of AIDS-associated Kaposi's sarcoma cells.
Murakami-Mori K; Mori S; Nakamura S
Biochem Biophys Res Commun; 1999 Nov; 264(3):676-82. PubMed ID: 10543991
[TBL] [Abstract][Full Text] [Related]
7. Correlation of oncostatin M secretion by human retrovirus-infected cells with potent growth stimulation of cultured spindle cells from AIDS-Kaposi's sarcoma.
Radka SF; Nakamura S; Sakurada S; Salahuddin SZ
J Immunol; 1993 Jun; 150(11):5195-201. PubMed ID: 8098726
[TBL] [Abstract][Full Text] [Related]
8. An unexpected biochemical and functional interaction between gp130 and the EGF receptor family in breast cancer cells.
Grant SL; Hammacher A; Douglas AM; Goss GA; Mansfield RK; Heath JK; Begley CG
Oncogene; 2002 Jan; 21(3):460-74. PubMed ID: 11821958
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1.
Kortylewski M; Heinrich PC; Mackiewicz A; Schniertshauer U; Klingmüller U; Nakajima K; Hirano T; Horn F; Behrmann I
Oncogene; 1999 Jun; 18(25):3742-53. PubMed ID: 10391682
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin E(2) stimulates prostatic intraepithelial neoplasia cell growth through activation of the interleukin-6/GP130/STAT-3 signaling pathway.
Liu XH; Kirschenbaum A; Lu M; Yao S; Klausner A; Preston C; Holland JF; Levine AC
Biochem Biophys Res Commun; 2002 Jan; 290(1):249-55. PubMed ID: 11779161
[TBL] [Abstract][Full Text] [Related]
11. Oncostatin M (OM) promotes the growth of DU 145 human prostate cancer cells, but not PC-3 or LNCaP, through the signaling of the OM specific receptor.
Mori S; Murakami-Mori K; Bonavida B
Anticancer Res; 1999; 19(2A):1011-5. PubMed ID: 10368647
[TBL] [Abstract][Full Text] [Related]
12. [Signal of the cytoplasmic regions of leukemia inhibitory factor receptor (LIFR) alpha-subunit and gp130 involves Stat3 activation in leukemic U937 cells].
Liu H; Tang S; Liu S
Zhonghua Xue Ye Xue Za Zhi; 1999 Dec; 20(12):621-3. PubMed ID: 11721361
[TBL] [Abstract][Full Text] [Related]
13. Resistance to interleukin 6 in human non-small cell lung carcinoma cell lines: role of receptor components.
Ganapathi MK; Weizer AK; Borsellino S; Bukowski RM; Ganapathi R; Rice T; Casey G; Kawamura K
Cell Growth Differ; 1996 Jul; 7(7):923-9. PubMed ID: 8809410
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of AIDS-Kaposi's sarcoma cell proliferation following retinoic acid receptor activation.
Guo WX; Gill PS; Antakly T
Cancer Res; 1995 Feb; 55(4):823-9. PubMed ID: 7850796
[TBL] [Abstract][Full Text] [Related]
15. FR901228, an inhibitor of histone deacetylases, increases the cellular responsiveness to IL-6 type cytokines by enhancing the expression of receptor proteins.
Blanchard F; Kinzie E; Wang Y; Duplomb L; Godard A; Held WA; Asch BB; Baumann H
Oncogene; 2002 Sep; 21(41):6264-77. PubMed ID: 12214267
[TBL] [Abstract][Full Text] [Related]
16. AIDS-related Kaposi's sarcoma cells rapidly internalize endostatin, which co-localizes to tropomysin microfilaments and inhibits cytokine-mediated migration and invasion.
Mallery SR; Morse MA; Wilson RF; Pei P; Ness GM; Bradburn JE; Renner RJ; Schuller DE; Robertson FM
J Cell Biochem; 2003 May; 89(1):133-43. PubMed ID: 12682914
[TBL] [Abstract][Full Text] [Related]
17. Oncostatin M activates phosphatidylinositol-3-kinase in Kaposi's sarcoma cells.
Soldi R; Graziani A; Benelli R; Ghigo D; Bosia A; Albini A; Bussolino F
Oncogene; 1994 Aug; 9(8):2253-60. PubMed ID: 8036010
[TBL] [Abstract][Full Text] [Related]
18. Expression of interleukin-6 receptors and NF-kappa B in AIDS-related Kaposi sarcoma cell strains.
Bailer RT; Ng-Bautista CL; Ness GM; Mallery SR
Lymphology; 1997 Jun; 30(2):63-76. PubMed ID: 9215976
[TBL] [Abstract][Full Text] [Related]
19. STAT3 is dispensable for maintenance of self-renewal in nonhuman primate embryonic stem cells.
Sumi T; Fujimoto Y; Nakatsuji N; Suemori H
Stem Cells; 2004; 22(5):861-72. PubMed ID: 15342949
[TBL] [Abstract][Full Text] [Related]
20. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors.
Hirano T; Ishihara K; Hibi M
Oncogene; 2000 May; 19(21):2548-56. PubMed ID: 10851053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
